Bookmark

Add to MyYahoo RSS

Nubain, Nalbuphine News

News on Nubain, Nalbuphine (generic) continually updated from thousands of sources around the net.

Monday Jul 14 | BioSpace

Trevi Therapeutics Announces Initiation Of A Pivotal Study Of Nalbuphine ER In Uremic Pruritus

Trevi Therapeutics, Inc. , a clinical stage biotechnology company developing Nalbuphine ER for chronic pruritus conditions, today announced the first patient enrolled in the pivotal study of Nalbuphine ER in hemodialysis patients with uremic pruritus.

Comment?

Related Topix: Medicine

Wed Jun 11, 2014

Hispanic Business

Trevi Therapeutics Announces $25 Million Series B Financing Led by...

" or the "Company"), a clinical stage biotechnology company developing Nalbuphine ER for chronic pruritus conditions, announced a Series B financing of ).

Comment?

Related Topix: Medicine, Venture Capital, Emerging Technology

Tue Jun 10, 2014

Hispanic Business

Trevi Therapeutics Reports $25 Million Series B Financing Led by TPG Biotech

The Company plans to use the funding for the initiation of pivotal trials in two severe itch conditions: uremic pruritus and prurigo nodularis.

Comment?

Related Topix: Venture Capital, Emerging Technology, Biotech, Science / Technology, Medicine

Wed Jun 04, 2014

BioSpace

Clinical Stage Biotech Trevi Therapeuitcs Brings In $25 Million Series B Financing

Trevi Therapeutics Announces $25 Million Series B Financing Led by TPG Biotech for Development of Nalbuphine ER NEW HAVEN, Conn.-- --Trevi Therapeutics, Inc. , a clinical stage biotechnology company developing Nalbuphine ER for chronic pruritus conditions, today announced a Series B financing of $25 million led by TPG Biotech, the life science ... (more)

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Venture Capital, Emerging Technology, New Haven, CT

Wed May 21, 2014

Hispanic Business

Trevi Therapeutics Exhibits Poster at 2014 Annual Meeting of the...

Nalbuphine ER was dose escalated every three days from 30 mg to 240 mg BID over 17 days.

Comment?

Related Topix: Medicine, Pharmacology

•••
•••
•••
•••
•••
•••
•••